Matthew J. Robson, Ph.D.
Matthew J. Robson, Ph.D.
Dent Neurologic Institute or West Virginia University or Vanderbilt University or Florida Atlantic
Email verificata su uc.edu
Titolo
Citata da
Citata da
Anno
Role of sigma-1 receptors in neurodegenerative diseases
L Nguyen, BP Lucke-Wold, SA Mookerjee, JZ Cavendish, MJ Robson, ...
Journal of pharmacological sciences 127 (1), 17-29, 2015
1562015
Sigma receptors: potential targets for a new class of antidepressant drug
JA Fishback, MJ Robson, YT Xu, RR Matsumoto
Pharmacology & therapeutics 127 (3), 271-282, 2010
1212010
Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis
FM Gengo, L Rubin, M Robson, M Rainka, MF Gengo, DE Mager, V Bates
The Journal of Clinical Pharmacology 48 (1), 117-122, 2008
702008
Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan
L Nguyen, MJ Robson, JR Healy, AL Scandinaro, RR Matsumoto
PloS one 9 (2), e89985, 2014
692014
Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo
MJ Robson, M Elliott, MJ Seminerio, RR Matsumoto
European Neuropsychopharmacology 22 (4), 308-317, 2012
692012
Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment?
RC Turner, B Lucke-Wold, MJ Robson, B Omalu, AL Petraglia, JE Bailes
Frontiers in neurology 3, 186, 2013
662013
Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats
RC Turner, ZJ Naser, AF Logsdon, KH DiPasquale, GJ Jackson, ...
Experimental neurology 248, 520-529, 2013
582013
Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events
FM Gengo, M Rainka, M Robson, MF Gengo, A Forrest, M Hourihane, ...
The Journal of Clinical Pharmacology 48 (3), 335-343, 2008
582008
Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia
RR Matsumoto, MJ Seminerio, RC Turner, MJ Robson, L Nguyen, ...
Pharmacology & therapeutics 144 (1), 28-40, 2014
572014
Sigma-1 receptors: potential targets for the treatment of substance abuse
M J Robson, B Noorbakhsh, M J Seminerio, R R Matsumoto
Current pharmaceutical design 18 (7), 902-919, 2012
572012
Cell-type-specific interleukin 1 receptor 1 signaling in the brain regulates distinct neuroimmune activities
X Liu, DP Nemeth, DB McKim, L Zhu, DJ DiSabato, O Berdysz, G Gorantla, ...
Immunity 50 (2), 317-333. e6, 2019
562019
Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects
RR Matsumoto, L Nguyen, N Kaushal, MJ Robson
Advances in Pharmacology 69, 323-386, 2014
482014
Immune system activation and depression: roles of serotonin in the central nervous system and periphery
MJ Robson, MA Quinlan, RD Blakely
ACS chemical neuroscience 8 (5), 932-942, 2017
432017
Synthesis and pharmacological evaluation of indole-based sigma receptor ligands
C Msangeau, E Amata, W Alsharif, MJ Seminerio, MJ Robson, ...
European journal of medicinal chemistry 46 (10), 5154-5161, 2011
422011
Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms
AF Logsdon, RC Turner, BP Lucke-Wold, MJ Robson, ZJ Naser, KE Smith, ...
Frontiers in cellular neuroscience 8, 421, 2014
412014
SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation
MJ Robson, RC Turner, ZJ Naser, CR McCurdy, JD Huber, ...
Experimental neurology 247, 134-142, 2013
412013
SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation
MJ Robson, RC Turner, ZJ Naser, CR McCurdy, JP O'Callaghan, ...
Experimental neurology 254, 180-189, 2014
402014
Alzheimer’s disease and chronic traumatic encephalopathy: Distinct but possibly overlapping disease entities
RC Turner, BP Lucke-Wold, MJ Robson, JM Lee, JE Bailes
Brain injury 30 (11), 1279-1292, 2016
372016
The quest to model chronic traumatic encephalopathy: a multiple model and injury paradigm experience
RC Turner, BP Lucke-Wold, AF Logsdon, MJ Robson, ML Dashnaw, ...
Frontiers in neurology 6, 222, 2015
372015
Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl) piperazin-1-yl) butyl) benzo [d] oxazol-2 (3H)-one (SN79), a cocaine antagonist, in rodents
N Kaushal, MJ Robson, H Vinnakota, S Narayanan, BA Avery, ...
The AAPS journal 13 (3), 336-346, 2011
342011
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20